Sun Pharma Advanced Research Company Limited
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
01 / The disclosure
What the company shared
Sun Pharma Advanced Research Company Limited has informed the Exchange about update on Litigation.
A question for your research
Check the authority, amount, company response and appeal status. A notice and a final liability are different stages.
Numbers found in document text 1 matches
Automatic text matches, not verified financial metrics. A match may come from a table heading or reporting year. Expand it to inspect the surrounding text and original page.
Rs. 2751 LakhsPage 2
The Tribunal has upheld the Order -in- Appeal dated 27.04.2018 passed in favour of the Company and confirmed the Company's entitlement to refund of accumulated CENVAT credit along with consequential interest, where applicable for an amount of Rs. 2751 Lakhs.
View source pageThe evidence
Read the source excerpts
01The Tribunal has upheld the Order -in- Appeal dated 27.04.2018 passed in favour of the Company and confirmed the Company's entitlement to refund of accumulated CENVAT credit along with consequential interest, where applicable for an amount of Rs. 2751 Lakhs.
Page 2
02Accordingly, the litigation stands decided in favour of the Company and the Revenue's appeal has been dismissed.
Page 2
03Not Applicable 3 In the event of settlement of the proceedings, details of such settlement including -terms of the settlement, compensation/penalty paid (if any) and impact of such settlement on the financial position of the listed entity Not Applicable
Page 2
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106806444
- First collected
- 4 Oct 2026, 13:21 IST
- PDF extraction
- extracted · 2 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- ac146e1a66f4940a2d97d2ab0280e4f0c38746d71f9713d8132d8212beb62b43